TMC125 (Etravirine) | HIV-1 reverse transcriptase inhibitor

Loading... Please wait...

New Products

Biologix SBS Format Cryogenic Vials-1mL, 2mL, 5mL, 48-Well, Racked, External Thread, 10 Sets/Pack, 2 Packs/Case

$253.89

Choose Options
Cryogenic Vials with Side Bardcode-2.0 ml External Thread

$67.49

Choose Options
Biologix Beakers-50/100/250/400/800/1000ml, Case of 100

$22.99

Choose Options
CryoKING Liquid Nitrogen Tank - Laboratory Series 31.5 L/35.5 L, Including 6 Square Racks(4 layers) with 5*5 Cryogenic Boxes

$856.49

Choose Options
CryoKING Liquid Nitrogen Tank Portable Dewar Series 2L/3L/6L/10L

$228.19

Choose Options

Our Newsletter

TMC125 (Etravirine) | HIV-1 reverse transcriptase inhibitor

Price:

$89.00

Catalog #:

C8125-5

* Package Size:

5 mg (10 mM solution in DMSO)
5 mg (powder)
25 mg (powder)
100 mg (powder)

Quantity:

Product Description

TMC125 is a nonnucleoside reverse transcriptase inhibitor with an EC50 of 1.4 to 4.3 nM for wild-type HIV-1. Additionally, TMC125 is highly potent against a wide range of single-mutant and double-mutant NNRTI-resistant HIV-1 strains, including L100I, K103N, Y181C, and L100I+K103N, at EC50s of 3, 1, 7, and 19 nM, respectively. (1)

TMC125 is believed to have a high barrier to development of resistance in vitro based on multiplicity of infection experiments which confirm a profile distinct from other reverse transcriptase inhibitors. (2)

Technical information:

Chemical Formula:		C₂₀H₁₅BrN₆O
CAS #:		269055-15-4
Molecular Weight:		435.28
Purity:		> 98%
Appearance:		white
Chemical Name:		4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile
Solubility:		Up to 50 mM in DMSO
Synonyms:		TMC125, TMC-125, Etravirine

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4^oC desiccated, or store DMSO solution at -20^oC.

Reference:

1.	Andries et al., TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 2004, 48(12), 4680-4686. Pubmed ID: 15561844
2.	Vingerhoets et al., TMC125 Displays a High Genetic Barrier to the Development of Resistance: Evidence from In Vitro Selection Experiments. J. Virol. 2005, 79(20), 12773-12782. Pubmed ID: 16188980

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.